pillbase.ru

Rezurock

Active substance: belumosudil

TABLET · BELUMOSUDIL 200 mg/1

United StatesActive

Marketing holder: Kadmon Pharmaceuticals, LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • Резтирег
    таблетки, покрытые пленочной оболочкой, 200 мг (original in Russian, GRLS)
    ЛП-№(009274)-(РГ-RU)
    АО "Санофи Россия"
EU 1
  • Rezurock
    belumosudil mesilate
    EMEA/H/C/006421
    Sanofi Winthrop Industrie
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-a2c2-7074-a380-61c940ed8fdb;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-c788-78af-8e50-26cea0de88a3;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
79802-200
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 79802-200 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 79802-200 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 79802-200 · Verified 2026-10-09 · open in source